Transarterial chemoembolization combined with metformin improves the prognosis of hepatocellular carcinoma patients with type 2 diabetes

Transarterial chemoembolization combined with metformin improves the prognosis of hepatocellular carcinoma patients with type 2 diabetes

ObjectiveThe study aims to investigate the effect of metformin on Hepatocellular carcinoma (HCC) patients with type 2 diabetes mellitus (T2DM) who received transarterial chemoembolization (TACE) for the first time.MethodsFrom January 2016 to December 2019, T2DM patients diagnosed with HCC in Shandon...

Full description

Bibliographic Details
Main Authors: Miao-Ling Chen, Chun-Xue Wu, Jian-Bo Zhang, Hao Zhang, Yuan-Dong Sun, Shi-Lin Tian, Jian-Jun Han
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Endocrinology
Subjects:
metformin
hepatocellular carcinoma
transarterial chem-embolization
type 2 diabetes mellitus
prognosis
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2022.996228/full

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2022.996228/full

Similar Items